{"transactions":[{"id":3860780,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":164741,"kind":"organization","name":"Presidio Partners 2007 GP, L.P.","position":1,"cik":"0001425386","reported_name":"Presidio Partners 2007 GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":164742,"kind":"organization","name":"Presidio Partners 2007 (Parallel), L.P.","position":2,"cik":"0001405972","reported_name":"Presidio Partners 2007 (Parallel), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":164743,"kind":"organization","name":"Presidio Partners 2007, L.P.","position":3,"cik":"0001405712","reported_name":"Presidio Partners 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":151681,"kind":"person","name":"Collier David J","position":4,"cik":"0001340886","reported_name":"Collier David J","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":151682,"kind":"person","name":"Watson James F","position":5,"cik":"0001420406","reported_name":"Watson James F","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":164744,"kind":"person","name":"Sohail Faysal A.","position":6,"cik":"0001425394","reported_name":"Sohail Faysal A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2018-07-26T19:11:02.000Z","date":"2018-07-24","kind":"sale","acquired":false,"shares":12500,"price":7.65,"value":95625.0,"ownership":{"direct":false,"nature":"By Presidio Partners 2007 (Parallel), L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities directly held by Presidio Partners 2007 (Parallel), L.P. (\"Presidio Parallel\"). Presidio GP is the sole general partner of Presidio Parallel. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio Parallel, and may be deemed to have voting control and investment power over the securities held by Presidio Parallel, but disclaim beneficial ownership of the securities held by Presidio Parallel, except to the extent of their pecuniary interest therein."}],"balance_after":48910,"source":{"system":"sec-edgar","filing":"0001144204-18-040247","document":"tv499325_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425386/000114420418040247/tv499325_4.xml","form_type":"4"}},{"id":3860779,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":164741,"kind":"organization","name":"Presidio Partners 2007 GP, L.P.","position":1,"cik":"0001425386","reported_name":"Presidio Partners 2007 GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":164742,"kind":"organization","name":"Presidio Partners 2007 (Parallel), L.P.","position":2,"cik":"0001405972","reported_name":"Presidio Partners 2007 (Parallel), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":164743,"kind":"organization","name":"Presidio Partners 2007, L.P.","position":3,"cik":"0001405712","reported_name":"Presidio Partners 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":151681,"kind":"person","name":"Collier David J","position":4,"cik":"0001340886","reported_name":"Collier David J","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":151682,"kind":"person","name":"Watson James F","position":5,"cik":"0001420406","reported_name":"Watson James F","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":164744,"kind":"person","name":"Sohail Faysal A.","position":6,"cik":"0001425394","reported_name":"Sohail Faysal A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2018-07-26T19:11:02.000Z","date":"2018-07-24","kind":"sale","acquired":false,"shares":487500,"price":7.65,"value":3729375.0,"ownership":{"direct":false,"nature":"By Presidio Partners 2007, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities directly held by Presidio Partners 2007, L.P. (\"Presidio Partners\"). Presidio Partners 2007 GP, L.P. (\"Presidio GP\") is the sole general partner of Presidio Partners. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio GP, and may be deemed to have voting control and investment power over the securities held by Presidio Partners, but disclaim beneficial ownership of the securities held by Presidio Partners, except to the extent of their pecuniary interest therein."}],"balance_after":1907568,"source":{"system":"sec-edgar","filing":"0001144204-18-040247","document":"tv499325_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425386/000114420418040247/tv499325_4.xml","form_type":"4"}},{"id":3860778,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":164741,"kind":"organization","name":"Presidio Partners 2007 GP, L.P.","position":1,"cik":"0001425386","reported_name":"Presidio Partners 2007 GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164742,"kind":"organization","name":"Presidio Partners 2007 (Parallel), L.P.","position":2,"cik":"0001405972","reported_name":"Presidio Partners 2007 (Parallel), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164743,"kind":"organization","name":"Presidio Partners 2007, L.P.","position":3,"cik":"0001405712","reported_name":"Presidio Partners 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151681,"kind":"person","name":"Collier David J","position":4,"cik":"0001340886","reported_name":"Collier David J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151682,"kind":"person","name":"Watson James F","position":5,"cik":"0001420406","reported_name":"Watson James F","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164744,"kind":"person","name":"Sohail Faysal A.","position":6,"cik":"0001425394","reported_name":"Sohail Faysal A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-07-26T18:54:17.000Z","date":"2018-03-02","kind":"other","acquired":true,"shares":152062,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By David J. Collier"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Velocity Pharmaceutical Development, LLC, of which the reporting person is a non-managing member."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities directly held by David J. Collier, M.D., a general partner of Presidio GP (as defined below), which is the sole general partner of Presidio Partners (as defined below)."}],"balance_after":152062,"source":{"system":"sec-edgar","filing":"0001144204-18-040243","document":"tv499460_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425386/000114420418040243/tv499460_form4.xml","form_type":"4"}},{"id":4086448,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":164741,"kind":"organization","name":"Presidio Partners 2007 GP, L.P.","position":1,"cik":"0001425386","reported_name":"Presidio Partners 2007 GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164742,"kind":"organization","name":"Presidio Partners 2007 (Parallel), L.P.","position":2,"cik":"0001405972","reported_name":"Presidio Partners 2007 (Parallel), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164743,"kind":"organization","name":"Presidio Partners 2007, L.P.","position":3,"cik":"0001405712","reported_name":"Presidio Partners 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151681,"kind":"person","name":"Collier David J","position":4,"cik":"0001340886","reported_name":"Collier David J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151682,"kind":"person","name":"Watson James F","position":5,"cik":"0001420406","reported_name":"Watson James F","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164744,"kind":"person","name":"Sohail Faysal A.","position":6,"cik":"0001425394","reported_name":"Sohail Faysal A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2018-01-29T16:25:53.000Z","date":"2018-01-29","kind":"exercise","acquired":false,"shares":21789,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Presidio Partners 2007 (Parallel), L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities directly held by Presidio Partners 2007 (Parallel), L.P. (\"Presidio Parallel\"). Presidio GP is the sole general partner of Presidio Parallel. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio Parallel, and may be deemed to have voting control and investment power over the securities held by Presidio Parallel, but disclaim beneficial ownership of the securities held by Presidio Parallel, except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3263},"source":{"system":"sec-edgar","filing":"0001209191-18-005852","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1425386/000120919118005852/doc4.xml","form_type":"4"}},{"id":4086447,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":164741,"kind":"organization","name":"Presidio Partners 2007 GP, L.P.","position":1,"cik":"0001425386","reported_name":"Presidio Partners 2007 GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164742,"kind":"organization","name":"Presidio Partners 2007 (Parallel), L.P.","position":2,"cik":"0001405972","reported_name":"Presidio Partners 2007 (Parallel), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164743,"kind":"organization","name":"Presidio Partners 2007, L.P.","position":3,"cik":"0001405712","reported_name":"Presidio Partners 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151681,"kind":"person","name":"Collier David J","position":4,"cik":"0001340886","reported_name":"Collier David J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151682,"kind":"person","name":"Watson James F","position":5,"cik":"0001420406","reported_name":"Watson James F","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164744,"kind":"person","name":"Sohail Faysal A.","position":6,"cik":"0001425394","reported_name":"Sohail Faysal A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2018-01-29T16:25:53.000Z","date":"2018-01-29","kind":"exercise","acquired":false,"shares":343310,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Presidio Partners 2007, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities directly held by Presidio Partners 2007 (Parallel), L.P. (\"Presidio Parallel\"). Presidio GP is the sole general partner of Presidio Parallel. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio Parallel, and may be deemed to have voting control and investment power over the securities held by Presidio Parallel, but disclaim beneficial ownership of the securities held by Presidio Parallel, except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":127269},"source":{"system":"sec-edgar","filing":"0001209191-18-005852","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1425386/000120919118005852/doc4.xml","form_type":"4"}},{"id":4086446,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":164741,"kind":"organization","name":"Presidio Partners 2007 GP, L.P.","position":1,"cik":"0001425386","reported_name":"Presidio Partners 2007 GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164742,"kind":"organization","name":"Presidio Partners 2007 (Parallel), L.P.","position":2,"cik":"0001405972","reported_name":"Presidio Partners 2007 (Parallel), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164743,"kind":"organization","name":"Presidio Partners 2007, L.P.","position":3,"cik":"0001405712","reported_name":"Presidio Partners 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151681,"kind":"person","name":"Collier David J","position":4,"cik":"0001340886","reported_name":"Collier David J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151682,"kind":"person","name":"Watson James F","position":5,"cik":"0001420406","reported_name":"Watson James F","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164744,"kind":"person","name":"Sohail Faysal A.","position":6,"cik":"0001425394","reported_name":"Sohail Faysal A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-01-29T16:25:53.000Z","date":"2018-01-29","kind":"exercise","acquired":false,"shares":58777,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Presidio Partners 2007 (Parallel), L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities directly held by Presidio Partners 2007 (Parallel), L.P. (\"Presidio Parallel\"). Presidio GP is the sole general partner of Presidio Parallel. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio Parallel, and may be deemed to have voting control and investment power over the securities held by Presidio Parallel, but disclaim beneficial ownership of the securities held by Presidio Parallel, except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21789},"source":{"system":"sec-edgar","filing":"0001209191-18-005852","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1425386/000120919118005852/doc4.xml","form_type":"4"}},{"id":4086445,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":164741,"kind":"organization","name":"Presidio Partners 2007 GP, L.P.","position":1,"cik":"0001425386","reported_name":"Presidio Partners 2007 GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164742,"kind":"organization","name":"Presidio Partners 2007 (Parallel), L.P.","position":2,"cik":"0001405972","reported_name":"Presidio Partners 2007 (Parallel), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164743,"kind":"organization","name":"Presidio Partners 2007, L.P.","position":3,"cik":"0001405712","reported_name":"Presidio Partners 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151681,"kind":"person","name":"Collier David J","position":4,"cik":"0001340886","reported_name":"Collier David J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151682,"kind":"person","name":"Watson James F","position":5,"cik":"0001420406","reported_name":"Watson James F","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164744,"kind":"person","name":"Sohail Faysal A.","position":6,"cik":"0001425394","reported_name":"Sohail Faysal A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-01-29T16:25:53.000Z","date":"2018-01-29","kind":"exercise","acquired":false,"shares":2292320,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Presidio Partners 2007, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities directly held by Presidio Partners 2007 (Parallel), L.P. (\"Presidio Parallel\"). Presidio GP is the sole general partner of Presidio Parallel. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio Parallel, and may be deemed to have voting control and investment power over the securities held by Presidio Parallel, but disclaim beneficial ownership of the securities held by Presidio Parallel, except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":849794},"source":{"system":"sec-edgar","filing":"0001209191-18-005852","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1425386/000120919118005852/doc4.xml","form_type":"4"}},{"id":4086444,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":164741,"kind":"organization","name":"Presidio Partners 2007 GP, L.P.","position":1,"cik":"0001425386","reported_name":"Presidio Partners 2007 GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164742,"kind":"organization","name":"Presidio Partners 2007 (Parallel), L.P.","position":2,"cik":"0001405972","reported_name":"Presidio Partners 2007 (Parallel), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164743,"kind":"organization","name":"Presidio Partners 2007, L.P.","position":3,"cik":"0001405712","reported_name":"Presidio Partners 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151681,"kind":"person","name":"Collier David J","position":4,"cik":"0001340886","reported_name":"Collier David J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151682,"kind":"person","name":"Watson James F","position":5,"cik":"0001420406","reported_name":"Watson James F","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164744,"kind":"person","name":"Sohail Faysal A.","position":6,"cik":"0001425394","reported_name":"Sohail Faysal A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-01-29T16:25:53.000Z","date":"2018-01-29","kind":"exercise","acquired":false,"shares":179,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Presidio Partners 2007 (Parallel), L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":66},"source":{"system":"sec-edgar","filing":"0001209191-18-005852","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1425386/000120919118005852/doc4.xml","form_type":"4"}},{"id":4086443,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":164741,"kind":"organization","name":"Presidio Partners 2007 GP, L.P.","position":1,"cik":"0001425386","reported_name":"Presidio Partners 2007 GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164742,"kind":"organization","name":"Presidio Partners 2007 (Parallel), L.P.","position":2,"cik":"0001405972","reported_name":"Presidio Partners 2007 (Parallel), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164743,"kind":"organization","name":"Presidio Partners 2007, L.P.","position":3,"cik":"0001405712","reported_name":"Presidio Partners 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151681,"kind":"person","name":"Collier David J","position":4,"cik":"0001340886","reported_name":"Collier David J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151682,"kind":"person","name":"Watson James F","position":5,"cik":"0001420406","reported_name":"Watson James F","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164744,"kind":"person","name":"Sohail Faysal A.","position":6,"cik":"0001425394","reported_name":"Sohail Faysal A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-01-29T16:25:53.000Z","date":"2018-01-29","kind":"exercise","acquired":false,"shares":6971,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Presidio Partners 2007, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2584},"source":{"system":"sec-edgar","filing":"0001209191-18-005852","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1425386/000120919118005852/doc4.xml","form_type":"4"}},{"id":4086442,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":164741,"kind":"organization","name":"Presidio Partners 2007 GP, L.P.","position":1,"cik":"0001425386","reported_name":"Presidio Partners 2007 GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164742,"kind":"organization","name":"Presidio Partners 2007 (Parallel), L.P.","position":2,"cik":"0001405972","reported_name":"Presidio Partners 2007 (Parallel), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164743,"kind":"organization","name":"Presidio Partners 2007, L.P.","position":3,"cik":"0001405712","reported_name":"Presidio Partners 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151681,"kind":"person","name":"Collier David J","position":4,"cik":"0001340886","reported_name":"Collier David J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151682,"kind":"person","name":"Watson James F","position":5,"cik":"0001420406","reported_name":"Watson James F","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164744,"kind":"person","name":"Sohail Faysal A.","position":6,"cik":"0001425394","reported_name":"Sohail Faysal A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-29T16:25:53.000Z","date":"2018-01-29","kind":"exercise","acquired":true,"shares":3263,"ownership":{"direct":false,"nature":"By Presidio Partners 2007 (Parallel), L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities directly held by Presidio Partners 2007 (Parallel), L.P. (\"Presidio Parallel\"). Presidio GP is the sole general partner of Presidio Parallel. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio Parallel, and may be deemed to have voting control and investment power over the securities held by Presidio Parallel, but disclaim beneficial ownership of the securities held by Presidio Parallel, except to the extent of their pecuniary interest therein."}],"balance_after":61410,"source":{"system":"sec-edgar","filing":"0001209191-18-005852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1425386/000120919118005852/doc4.xml","form_type":"4"}},{"id":4086441,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":164741,"kind":"organization","name":"Presidio Partners 2007 GP, L.P.","position":1,"cik":"0001425386","reported_name":"Presidio Partners 2007 GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164742,"kind":"organization","name":"Presidio Partners 2007 (Parallel), L.P.","position":2,"cik":"0001405972","reported_name":"Presidio Partners 2007 (Parallel), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164743,"kind":"organization","name":"Presidio Partners 2007, L.P.","position":3,"cik":"0001405712","reported_name":"Presidio Partners 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151681,"kind":"person","name":"Collier David J","position":4,"cik":"0001340886","reported_name":"Collier David J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151682,"kind":"person","name":"Watson James F","position":5,"cik":"0001420406","reported_name":"Watson James F","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164744,"kind":"person","name":"Sohail Faysal A.","position":6,"cik":"0001425394","reported_name":"Sohail Faysal A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-29T16:25:53.000Z","date":"2018-01-29","kind":"exercise","acquired":true,"shares":127269,"ownership":{"direct":false,"nature":"By Presidio Partners 2007, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities directly held by Presidio Partners 2007 (Parallel), L.P. (\"Presidio Parallel\"). Presidio GP is the sole general partner of Presidio Parallel. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio Parallel, and may be deemed to have voting control and investment power over the securities held by Presidio Parallel, but disclaim beneficial ownership of the securities held by Presidio Parallel, except to the extent of their pecuniary interest therein."}],"balance_after":2395068,"source":{"system":"sec-edgar","filing":"0001209191-18-005852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1425386/000120919118005852/doc4.xml","form_type":"4"}},{"id":4086440,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":164741,"kind":"organization","name":"Presidio Partners 2007 GP, L.P.","position":1,"cik":"0001425386","reported_name":"Presidio Partners 2007 GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164742,"kind":"organization","name":"Presidio Partners 2007 (Parallel), L.P.","position":2,"cik":"0001405972","reported_name":"Presidio Partners 2007 (Parallel), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164743,"kind":"organization","name":"Presidio Partners 2007, L.P.","position":3,"cik":"0001405712","reported_name":"Presidio Partners 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151681,"kind":"person","name":"Collier David J","position":4,"cik":"0001340886","reported_name":"Collier David J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151682,"kind":"person","name":"Watson James F","position":5,"cik":"0001420406","reported_name":"Watson James F","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164744,"kind":"person","name":"Sohail Faysal A.","position":6,"cik":"0001425394","reported_name":"Sohail Faysal A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-29T16:25:53.000Z","date":"2018-01-29","kind":"exercise","acquired":true,"shares":21789,"ownership":{"direct":false,"nature":"By Presidio Partners 2007 (Parallel), L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities directly held by Presidio Partners 2007 (Parallel), L.P. (\"Presidio Parallel\"). Presidio GP is the sole general partner of Presidio Parallel. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio Parallel, and may be deemed to have voting control and investment power over the securities held by Presidio Parallel, but disclaim beneficial ownership of the securities held by Presidio Parallel, except to the extent of their pecuniary interest therein."}],"balance_after":58147,"source":{"system":"sec-edgar","filing":"0001209191-18-005852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1425386/000120919118005852/doc4.xml","form_type":"4"}},{"id":4086439,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":164741,"kind":"organization","name":"Presidio Partners 2007 GP, L.P.","position":1,"cik":"0001425386","reported_name":"Presidio Partners 2007 GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164742,"kind":"organization","name":"Presidio Partners 2007 (Parallel), L.P.","position":2,"cik":"0001405972","reported_name":"Presidio Partners 2007 (Parallel), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164743,"kind":"organization","name":"Presidio Partners 2007, L.P.","position":3,"cik":"0001405712","reported_name":"Presidio Partners 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151681,"kind":"person","name":"Collier David J","position":4,"cik":"0001340886","reported_name":"Collier David J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151682,"kind":"person","name":"Watson James F","position":5,"cik":"0001420406","reported_name":"Watson James F","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164744,"kind":"person","name":"Sohail Faysal A.","position":6,"cik":"0001425394","reported_name":"Sohail Faysal A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-29T16:25:53.000Z","date":"2018-01-29","kind":"exercise","acquired":true,"shares":849794,"ownership":{"direct":false,"nature":"By Presidio Partners 2007, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities directly held by Presidio Partners 2007, L.P. (\"Presidio Partners\"). Presidio Partners 2007 GP, L.P. (\"Presidio GP\") is the sole general partner of Presidio Partners. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio GP, and may be deemed to have voting control and investment power over the securities held by Presidio Partners, but disclaim beneficial ownership of the securities held by Presidio Partners, except to the extent of their pecuniary interest therein."}],"balance_after":2267799,"source":{"system":"sec-edgar","filing":"0001209191-18-005852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425386/000120919118005852/doc4.xml","form_type":"4"}},{"id":4086438,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":164741,"kind":"organization","name":"Presidio Partners 2007 GP, L.P.","position":1,"cik":"0001425386","reported_name":"Presidio Partners 2007 GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164742,"kind":"organization","name":"Presidio Partners 2007 (Parallel), L.P.","position":2,"cik":"0001405972","reported_name":"Presidio Partners 2007 (Parallel), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164743,"kind":"organization","name":"Presidio Partners 2007, L.P.","position":3,"cik":"0001405712","reported_name":"Presidio Partners 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151681,"kind":"person","name":"Collier David J","position":4,"cik":"0001340886","reported_name":"Collier David J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151682,"kind":"person","name":"Watson James F","position":5,"cik":"0001420406","reported_name":"Watson James F","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164744,"kind":"person","name":"Sohail Faysal A.","position":6,"cik":"0001425394","reported_name":"Sohail Faysal A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-29T16:25:53.000Z","date":"2018-01-29","kind":"exercise","acquired":true,"shares":66,"ownership":{"direct":false,"nature":"By Presidio Partners 2007 (Parallel), L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities directly held by Presidio Partners 2007, L.P. (\"Presidio Partners\"). Presidio Partners 2007 GP, L.P. (\"Presidio GP\") is the sole general partner of Presidio Partners. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio GP, and may be deemed to have voting control and investment power over the securities held by Presidio Partners, but disclaim beneficial ownership of the securities held by Presidio Partners, except to the extent of their pecuniary interest therein."}],"balance_after":36358,"source":{"system":"sec-edgar","filing":"0001209191-18-005852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425386/000120919118005852/doc4.xml","form_type":"4"}},{"id":4086437,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":164741,"kind":"organization","name":"Presidio Partners 2007 GP, L.P.","position":1,"cik":"0001425386","reported_name":"Presidio Partners 2007 GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164742,"kind":"organization","name":"Presidio Partners 2007 (Parallel), L.P.","position":2,"cik":"0001405972","reported_name":"Presidio Partners 2007 (Parallel), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164743,"kind":"organization","name":"Presidio Partners 2007, L.P.","position":3,"cik":"0001405712","reported_name":"Presidio Partners 2007, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151681,"kind":"person","name":"Collier David J","position":4,"cik":"0001340886","reported_name":"Collier David J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":151682,"kind":"person","name":"Watson James F","position":5,"cik":"0001420406","reported_name":"Watson James F","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164744,"kind":"person","name":"Sohail Faysal A.","position":6,"cik":"0001425394","reported_name":"Sohail Faysal A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-29T16:25:53.000Z","date":"2018-01-29","kind":"exercise","acquired":true,"shares":2584,"ownership":{"direct":false,"nature":"By Presidio Partners 2007, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities directly held by Presidio Partners 2007, L.P. (\"Presidio Partners\"). Presidio Partners 2007 GP, L.P. (\"Presidio GP\") is the sole general partner of Presidio Partners. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio GP, and may be deemed to have voting control and investment power over the securities held by Presidio Partners, but disclaim beneficial ownership of the securities held by Presidio Partners, except to the extent of their pecuniary interest therein."}],"balance_after":1418005,"source":{"system":"sec-edgar","filing":"0001209191-18-005852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425386/000120919118005852/doc4.xml","form_type":"4"}}]}